Schedule of Assets and liabilities at Fair Value on Recurring Basis |
Assets and liabilities carried at fair value on a recurring basis consisted of the following (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30, 2023 |
|
December 31, 2022 |
|
Fair Value |
|
Level 1 |
|
Level 2 |
|
Level 3 |
|
Fair Value |
|
Level 1 |
|
Level 2 |
|
Level 3 |
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets held in rabbi trust |
$ |
10,365 |
|
|
$ |
— |
|
|
$ |
10,365 |
|
|
$ |
— |
|
|
$ |
9,553 |
|
|
$ |
— |
|
|
$ |
9,553 |
|
|
$ |
— |
|
Cash equivalents (1):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial paper |
$ |
50,191 |
|
|
$ |
— |
|
|
$ |
50,191 |
|
|
$ |
— |
|
|
$ |
41,324 |
|
|
$ |
— |
|
|
$ |
41,324 |
|
|
$ |
— |
|
Money market funds |
81,411 |
|
|
81,411 |
|
|
— |
|
|
— |
|
|
139,025 |
|
|
139,025 |
|
|
— |
|
|
— |
|
|
$ |
131,602 |
|
|
$ |
81,411 |
|
|
$ |
50,191 |
|
|
$ |
— |
|
|
$ |
180,349 |
|
|
$ |
139,025 |
|
|
$ |
41,324 |
|
|
$ |
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Marketable debt securities, available-for-sale: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-term investments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. treasuries |
$ |
65,495 |
|
|
$ |
65,495 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
134,549 |
|
|
$ |
134,549 |
|
|
$ |
— |
|
|
$ |
— |
|
Corporate debt |
99,361 |
|
|
— |
|
|
99,361 |
|
|
— |
|
|
118,041 |
|
|
— |
|
|
118,041 |
|
|
— |
|
ABS and other |
— |
|
|
— |
|
|
— |
|
|
— |
|
|
844 |
|
|
— |
|
|
844 |
|
|
— |
|
|
$ |
164,856 |
|
|
$ |
65,495 |
|
|
$ |
99,361 |
|
|
$ |
— |
|
|
$ |
253,434 |
|
|
$ |
134,549 |
|
|
$ |
118,885 |
|
|
$ |
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-term investments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. treasuries |
$ |
17,409 |
|
|
$ |
17,409 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
20,715 |
|
|
$ |
20,715 |
|
|
$ |
— |
|
|
$ |
— |
|
U.S. government sponsored entities |
510 |
|
|
— |
|
|
510 |
|
|
— |
|
|
536 |
|
|
— |
|
|
536 |
|
|
— |
|
Corporate debt |
42,250 |
|
|
— |
|
|
42,250 |
|
|
— |
|
|
41,358 |
|
|
— |
|
|
41,358 |
|
|
— |
|
ABS and other |
10,542 |
|
|
— |
|
|
10,542 |
|
|
— |
|
|
5,986 |
|
|
— |
|
|
5,986 |
|
|
— |
|
|
$ |
70,711 |
|
|
$ |
17,409 |
|
|
$ |
53,302 |
|
|
$ |
— |
|
|
$ |
68,595 |
|
|
$ |
20,715 |
|
|
$ |
47,880 |
|
|
$ |
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Contingent consideration |
$ |
6,518 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
6,518 |
|
|
$ |
7,067 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
7,067 |
|
Deferred consideration |
$ |
2,018 |
|
|
$ |
— |
|
|
$ |
2,018 |
|
|
$ |
— |
|
|
$ |
5,119 |
|
|
$ |
— |
|
|
$ |
5,119 |
|
|
$ |
— |
|
Deferred compensation liability |
$ |
8,086 |
|
|
$ |
8,086 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
6,661 |
|
|
$ |
6,661 |
|
|
$ |
— |
|
|
$ |
— |
|
|
|
|
|
|
|
(1) |
Included in cash, cash equivalents, and restricted cash on the accompanying condensed consolidated balance sheets. |
|